Italy’s $10 Billion Pharma Family Makes A U.S. Power Move
For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe.
Now it’s bought its way into the U.S. market.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.forbes.com — the content belongs to Forbes.